Get startedLog in
    Picture of Calithera Biosciences logo

    CALA — Calithera Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Final Data From Calithera Biosciences’ Phase 2 Cantata Study In Renal Cell Carcinoma Presented At 2021 Asco Annual Meeting

    Picture of Calithera Biosciences logoCalithera Biosciences
    07/06/2021 13:46
    June 7 (Reuters) - Calithera Biosciences Inc  CALA.O :
    * FINAL DATA FROM CALITHERA BIOSCIENCES’ PHASE 2 CANTATA
STUDY IN
RENAL CELL CARCINOMA PRESENTED AT 2021 ASCO ANNUAL MEETING

Source text for Eikon:  ID:nGNX6TJq3M 
Further company coverage:  CALA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Calithera Biosciences

    See all news